Department of Neurology, Samsung Medical Centre, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul 135-710, Republic of Korea.
J Clin Neurosci. 2013 Jul;20(7):938-42. doi: 10.1016/j.jocn.2012.08.007. Epub 2013 May 11.
Neuromyelitis optica (NMO) is an inflammatory demyelinating disorder that predominantly affects the optic nerve and spinal cord; however, symptomatic brain involvement is not rare and is sometimes an initial manifestation in NMO. In this study, we investigated the characteristic features of patients with NMO with symptomatic brain involvement as the initial manifestation of disease (NMO(brain)) compared with patients with NMO who presented initially with optic neuritis or myelitis (NMO(ON/myelitis)). We retrospectively reviewed 27 consecutive Korean patients with NMO with aquaporin-4 antibodies. Patients with NMO(brain) (n=9) initially presented with intractable hiccup/nausea/vomiting and/or encephalopathy at a younger age than the patients with NMO(ON/myelitis) (n=18) (p<0.01). During the disease course, the patients with NMO(brain) continued to show more frequent symptomatic involvement of the brain than the 18 patients with NMO(ON/myelitis) (p<0.05). At the final visit, the mean age was also significantly lower in patients with NMO(brain) than in patients with NMO(ON/myelitis) (p<0.01); however, the Expanded Disability Status Scale scores, used to evaluate disease progression, were not different between the two groups. Our study suggests that patients with NMO who present initially with symptomatic brain involvement may have earlier disease onset and become disabled at a younger age compared to patients with typical NMO. Additional large scale prospective studies are warranted.
视神经脊髓炎(NMO)是一种以视神经和脊髓为主的炎症性脱髓鞘疾病;然而,症状性脑受累并不罕见,且在 NMO 中有时为首发表现。在这项研究中,我们比较了以疾病首发症状性脑受累为表现的 NMO 患者(NMO(脑))与以视神经炎或脊髓炎为首发表现的 NMO 患者(NMO(ON/脊髓炎))的特征。我们回顾性分析了 27 例连续的韩国抗水通道蛋白 4 抗体阳性的 NMO 患者。与 NMO(ON/脊髓炎)患者(n=18)相比,NMO(脑)患者(n=9)首发症状为顽固性呃逆/恶心/呕吐和/或脑病的年龄更小(p<0.01)。在疾病过程中,NMO(脑)患者的脑症状性受累频率比 18 例 NMO(ON/脊髓炎)患者更高(p<0.05)。在最后一次就诊时,NMO(脑)患者的平均年龄也明显低于 NMO(ON/脊髓炎)患者(p<0.01);然而,评估疾病进展的扩展残疾状况量表评分在两组间无差异。我们的研究表明,与典型 NMO 患者相比,以首发症状性脑受累为表现的 NMO 患者的疾病起始年龄更早,且在更年轻时残疾。需要开展更多的大型前瞻性研究。